News
Videos
Conferences
Events
Resources
Subscribe

Kathy Boltz, PhD

Articles by Kathy Boltz, PhD

Long-Term Data Show Optune Offers a Survival Benefit in Glioblastoma

ByKathy Boltz, PhD

November 21st 2016

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.

Latest Updated Articles

Long-Term Data Show Optune Offers a Survival Benefit in Glioblastoma
November 21st 2016

Trending on CURE

FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer

FDA Approves Ibrance Combo for Maintenance Treatment of HR-Positive, HER2-Positive Metastatic Breast Cancer

The Whole Person: How Susan Yaguda Is Redefining Cancer Care